Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alpha-synuclein (α-Syn) accumulation is central to Parkinson's disease (PD) pathogenesis.
• Genetic mutations in the SNCA gene (encoding α-Syn) confirm α-Syn's causative role in PD.
• Previous screens identified Doublecortin-like kinase 1 (DCLK1) as a key regulator of α-Syn.

Purpose of the Study:

• To investigate the functional relationship between DCLK1 and α-Syn in Parkinson's disease.
• To evaluate DCLK1 as a potential therapeutic target for reducing pathological α-Syn.

Main Methods:

• Post-transcriptional regulation analysis of α-Syn by DCLK1.
• Dclk1 knockdown in cellular and mouse models of synucleinopathy.
• Assessment of phosphorylated α-Syn levels and neurotoxicity in the substantia nigra (SNc).
• Silencing DCLK1 in human neurons with SNCA triplications.

Main Results:

• DCLK1 was confirmed to regulate α-Syn levels post-transcriptionally.
• Knockdown of Dclk1 significantly reduced phosphorylated α-Syn and α-Syn-induced neurotoxicity in mouse models.
• DCLK1 silencing decreased both total and phosphorylated α-Syn in human neurons derived from PD patients.

Conclusions:

• DCLK1 plays a critical role in regulating α-Syn levels and toxicity in the brain.
• DCLK1 inhibition represents a promising therapeutic strategy for synucleinopathies.
• This study uncovers a novel function for DCLK1 in the mature brain relevant to PD.